Custom vs Catalogue Peptides: Which Should You Choose?

What counts as a catalogue peptide

A catalogue peptide is a sequence that a supplier has already synthesized, characterized and listed for sale. Common examples include angiotensin II, bradykinin, substance P, glucagon-like peptide-1 fragments, amyloid beta fragments and a long list of epitopes and enzyme substrates. Because the sequence is fixed, the supplier can batch production, hold inventory and publish a specification that does not change from order to order.

The catalogue listing usually states the sequence, molecular weight, purity grade, salt form and available pack sizes. Some suppliers also stock several purity grades of the same peptide, so a buyer can choose between a screening grade and a 98% reference grade. What the buyer cannot change is the sequence itself, the terminal chemistry, or the presence of a label.

This is the right model for well-known reagents where the scientific question depends on a standard molecule. It is not the right model when the sequence is the invention.

Where custom synthesis is the only sensible choice

Custom synthesis becomes necessary whenever the sequence is not a published standard. That includes proprietary epitopes, truncated or mutated variants, alanine scans, stabilised analogues, and any peptide with a non-natural residue. It also includes cases where a standard sequence exists but the specification does not fit: a different counter-ion, a specific N-terminal label, a disulfide pairing that the catalogue version does not have, or a quantity far outside the catalogue pack sizes.

Regulated or documentation-heavy work often pushes a project to custom even when a catalogue peptide exists. If you need a lot made to a defined release specification, with sequence confirmation and a certificate that matches your internal quality requirements, custom manufacturing gives you control that an off-the-shelf vial may not. The same applies when a long study needs a single large lot, since catalogue inventory may be split across multiple batches.

Custom also makes sense when the peptide is difficult. A supplier who has reviewed your specific sequence can propose a route, flag aggregation risk and advise on solubility before synthesis. That technical dialogue is part of what the custom price buys.

Where catalogue peptides win

Speed and price are the obvious advantages. A catalogue peptide can ship the same week, sometimes the same day, and the per-milligram price is usually lower because the batch cost is shared across many customers. For assay development, method validation and pilot experiments, that speed often matters more than the ability to specify every detail.

Catalogue peptides also come with a known history. If hundreds of laboratories have used the same lot, the behaviour in common assays is documented, and a surprising result is less likely to be blamed on the reagent. For a standard curve or a positive control, that familiarity is worth something.

The limits are just as real. You cannot request a modification, and you may not be able to choose the salt form or the exact purity. Pack sizes may not match your needs, so you either buy too little and re-order or too much and waste material. And if the catalogue sequence is slightly different from the one your hypothesis requires, using it anyway introduces a variable you did not intend.

Cost comparison in practice

The comparison is not simply price per vial. Add the cost of re-ordering, the cost of a failed experiment caused by the wrong analogue, and the value of a single lot that covers the whole study. Custom synthesis often wins on total cost even when the invoice is larger. The cost drivers article explains how to normalise quotes.

Quality documentation in both cases

The distinction between catalogue and custom should not change the documentation standard. Both should arrive with a lot-specific certificate of analysis stating the sequence, molecular weight, purity by HPLC, the analytical method, the counter-ion, peptide content and the storage recommendation. Both should be traceable to a lot number printed on the vial.

In practice, catalogue documentation is sometimes thinner because the product is sold as a commodity. If you need a full package, ask for the lot-specific chromatogram and mass spectrum rather than a representative example from a previous batch. A supplier who cannot produce lot-specific data for a catalogue item is telling you something about their quality system.

Custom orders give you the opportunity to specify the analytical package in the quote, including MS/MS sequence confirmation, amino acid analysis or residual solvent testing. Use that opportunity if the application demands it, and check the certificate of analysis guide before you approve the specification.

A short decision checklist

Work through these questions in order. The first one that forces a specific answer usually settles the choice.

• Does an exact catalogue sequence exist? If no, custom is required.
• Do you need a modification or label? If yes, custom is almost always required.
• Is the catalogue purity and salt form acceptable for the assay? If no, custom is the cleaner route.
• Do you need more material than the catalogue pack size offers? A custom lot avoids mixing batches.
• Is the timeline measured in days rather than weeks? Catalogue wins if the sequence exists.
• Does the study need a single documented lot? Custom gives you control over batch size and release testing.

For projects that fall in between, ask a supplier to quote both. The comparison usually makes the trade-off obvious, and the ordering guide explains what information the custom quote will require.

MOL Changes supplies catalogue reagents and custom peptide synthesis from 5 mg to kilogram scale, with HPLC and mass spectrometry on every batch. If you are unsure which route fits, send the sequence and intended use and the technical team will advise.